Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug averts Parkinson’s disease in fruit flies, suggesting new approach for humans

12.11.2002


Scientists at the University of Pennsylvania have averted the onset of neurodegenerative disease in fruit flies by administering medication to flies genetically predisposed to a disorder akin to Parkinson’s disease.



The result suggests a new approach to the treatment of human disorders including Parkinson’s and Alzheimer’s diseases. Penn biologist Nancy M. Bonini and graduate student Pavan K. Auluck report the finding in the November issue of Nature Medicine.

Parkinson’s disease is the second most common human neurodegenerative disorder, characterized by tremors, postural rigidity and progressive deterioration of dopaminergic neurons in specific areas of the brain. Despite the evolutionary gulf separating humans and fruit flies, neurotoxicity unfolds in a similar manner in both species. Like humans, Drosophila melanogaster experiences neuronal loss upon expression of alpha-synuclein, a protein implicated in the onset of Parkinson’s disease in both species.


"Medications now prescribed to people with Parkinson’s disease, such as levodopa, bromocriptine and deprenyl, relieve symptoms by rescuing neurons compromised by the disease," said Bonini, Penn professor of biology and investigator with the Howard Hughes Medical Institute. "Our studies suggest that a new class of drugs might prevent neurodegenerative disorders by fortifying these neurons even before the onset of disease."

Bonini and Auluck fed flies a naturally occurring antibiotic called geldanamycin. When fed geldanamycin-supplemented food as adults, flies with a genetic susceptibility to neurodegenerative disease -- flies that would normally experience a 50 percent loss of dopaminergic neurons by 20 days of age -- maintained normal numbers of these neurons.

Geldanamycin tweaks the activity of Hsp90, one of a class of proteins known as molecular chaperones. Bonini, Auluck and colleagues showed last year that molecular chaperones can block the progression of neurodegenerative disease in Drosophila, suggesting that diseases like Parkinson’s and Alzheimer’s may result from reduced chaperone levels and might be averted by pharmacologically boosting chaperone activity.

Bonini cautions that there are limitations of geldanamycin itself, derivatives of which are now undergoing clinical trials as possible antitumor agents. However, she says these findings should stimulate chemists and pharmaceutical researchers on the trail of a new class of drugs that, by bolstering molecular chaperones, could prevent neurodegenerative disease from ever taking hold

"These studies have revealed a drug that can fully protect against the toxicity of alpha-synuclein to dopaminergic neurons in Drosophila," Bonini and Auluck write in Nature Medicine. "Geldanamycin and its derivatives warrant further exploration as cytoprotective agents for the treatment of neurodegenerative diseases involving alpha-synuclein toxicity, including Parkinson’s disease."


Bonini and Auluck’s work is funded by grants from the David and Lucile Packard Foundation, the National Institute on Aging, the National Institutes of Health and the Alzheimer’s Association.


Steve Bradt | EurekAlert!
Further information:
http://www.upenn.edu/

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Extensive Funding for Research on Chromatin, Adrenal Gland, and Cancer Therapy

28.06.2017 | Awards Funding

Predicting eruptions using satellites and math

28.06.2017 | Earth Sciences

Extremely fine measurements of motion in orbiting supermassive black holes

28.06.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>